Skip to main content

NORDEA INVESTMENT MANAGEMENT AB

Position in MYGN — Myriad Genetics Inc

CIK 1218210 STOCKHOLM, V7

Position in MYGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,536,673
-$733,604 QoQ
Shares Held
341,483
-7.5% QoQ
Ownership
0.362%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

NORDEA INVESTMENT MANAGEMENT AB holds $1,532,838,136 across 17 Diagnostics & Research names. MYGN ranks #17 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,536,673 341,483
2025-12-31 $2,270,277 369,151
2025-09-30 $3,009,060 416,191
2025-06-30 $2,139,451 402,910
2025-03-31 $2,990,334 337,129
2024-12-31 $4,564,236 332,913
2024-09-30 $4,201,241 153,386
2024-06-30 $3,953,763 161,642
2024-03-31 $2,748,211 128,903
2023-12-31 $2,336,917 122,096
2023-09-30 $2,042,036 127,309
2023-06-30 $3,056,120 131,843
2023-03-31 $4,164,325 179,265
2022-12-31 $2,641,298 182,033
2022-09-30 $3,837,541 201,129
2022-06-30 $3,673,937 202,198
2022-03-31 $5,644,069 223,971
2021-12-31 $6,097,447 220,922
2021-09-30 $7,187,463 222,591
2021-06-30 $6,710,536 219,442
2021-03-31 $4,141,017 135,994
2020-12-31 $2,734,566 138,319
2020-09-30 $1,851,719 142,003
2020-06-30 $3,220,628 284,006
2020-03-31 $1,991,751 139,186